Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Lymphoma, Follicular × Tirzepatide × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Obesity 2 Prostatic Neoplasms 1 Opioid-Related Disorders 1 Lymphoma, Follicular 1 Endometrial Hyperplasia 1 Diabetes Mellitus 1 Colorectal Neoplasms 1 Breast Neoplasms 1

Interventions

Rituximab 15 Cyclophosphamide 14 Lenalidomide 12 Prednisone 9 Vincristine 8 Doxorubicin 8 obinutuzumab 5 fludarabine 5 Specimen Handling 5 Magnetic Resonance Spectroscopy 5 R-CHOP protocol 4 Biopsy 4 Bendamustine Hydrochloride 4 zanubrutinib 3 ibrutinib 3 fludarabine phosphate 3 tisagenlecleucel 2 tazemetostat 2 Whole-Body Irradiation 2 Temozolomide 2 Radiotherapy 2 Prednisolone 2 Oxaliplatin 2 Gemcitabine 2 Cyclosporine 2 CT-P10 2 voruciclib 1 venetoclax 1 umbralisib 1 treosulfan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06651177 2026-03-05

TAB

University of Cincinnati

Phase 2 Recruiting

Lymphoma, Follicular, Opioid-Related Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚡